Results 81 to 90 of about 27,164 (223)

Spinocerebellar Ataxia Type 27 Patient with a New Mutational Locus: A Case Report-Supplementary File

open access: yes, 2022
Supplementary files of the manuscript Spinocerebellar Ataxia Type 27 Patient with a New Mutational Locus: A Case Report, which contains 3 videos: Sup. 1 physical examination-1, Sup. 2 physical examination-2, Sup.
Rong, Zhang
core   +1 more source

Magnetic resonance imaging for spinocerebellar ataxia: a bibliometric analysis based on web of science

open access: yesFrontiers in Neurology
The objective of this study was to review the history of magnetic resonance imaging (MRI) research on spinocerebellar ataxia (SCA) over the last 16 years.
Zhen-Yi Liu   +10 more
doaj   +1 more source

Phenotypic Exploration in Patients with Heterozygous Variant in AFG3L2 Gene: A Case‐Series and Literature Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Variants in AFG3‐Like Matrix AAA Peptidase, Subunit 2 (AFG3L2) gene are associated with diverse clinical phenotypes. Here, we describe phenotypic findings of two unrelated children with de novo heterozygous variant and one family with inherited heterozygous variant in AFG3L2 gene.
Sangeetha Yoganathan   +14 more
wiley   +1 more source

Paula Coutinho’s outstanding contribution to the definition of Machado-Joseph disease

open access: yesArquivos de Neuro-Psiquiatria
Machado-Joseph disease, also known as spinocerebellar ataxia type 3, is the most common form of autosomal dominant ataxia in the world. Paula Coutinho, a highly-regarded Portuguese neurologist worldwide, had a seminal participation in the definition of ...
Bruno Carniatto Marques Garcia   +4 more
doaj   +1 more source

Treatment of Spinocerebellar Ataxia with Mesenchymal Stem Cells: A Phase I/IIa Clinical Study

open access: yesCell Transplantation, 2017
Ataxia is one of the most devastating symptoms of many neurodegenerative disorders. As of today, there is not any effective treatment to retard its progression. Mesenchymal stem cells (MSCs) have shown promise in treating neurodegenerative diseases.
Yun-An Tsai   +9 more
doaj   +1 more source

The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research

open access: yesBiomedicines, 2023
Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 (SCA3) is the most common autosomal dominant ataxia worldwide. MJD is characterized by late-onset progressive cerebellar ataxia associated with variable clinical findings, including pyramidal ...
Manuela Lima   +14 more
doaj   +1 more source

Early and Progressive Spinal Cord Atrophy in Spinocerebellar Ataxia Type 1

open access: yesMovement Disorders, EarlyView.
Abstract Background Spinocerebellar ataxia type 1 (SCA1) is a rare, autosomal dominant neurodegenerative disorder characterized by progressive cerebellar and brainstem degeneration. Previous studies have shown that spinal cord atrophy is also a key aspect of SCA1 neuropathology.
Colette J.M. Reniers   +11 more
wiley   +1 more source

Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23 [PDF]

open access: yes, 2015
Item does not contain fulltextSpinocerebellar ataxia type 23 is caused by mutations in PDYN, which encodes the opioid neuropeptide precursor protein, prodynorphin.
Deursen, J.M.A. van   +54 more
core   +1 more source

A Severity‐Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA‐Ataxia

open access: yesMovement Disorders, EarlyView.
Background Spinocerebellar ataxia type 3 (SCA3) is a rare, inherited neurodegenerative disease characterized by progressive loss of motor coordination. Objectives We undertook a multisite magnetic resonance imaging study to profile the spatial spread of atrophy across the brain, determine whether atrophy preferentially maps onto specific functional ...
Jason W. Robertson   +43 more
wiley   +1 more source

Demographic and clinical data of the patients with cerebellar subtype multiple system atrophy (MSA-C), spinocerebellar ataxia type 3 (SCA3), and type 6 (SCA6) and controls.

open access: yes, 2022
Demographic and clinical data of the patients with cerebellar subtype multiple system atrophy (MSA-C), spinocerebellar ataxia type 3 (SCA3), and type 6 (SCA6) and controls.
Hiroki Mukai (1719136)   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy